For decades, gene therapy lived on the edge of possibility. Scientists promised cures at the molecular level. Investors poured billions into biotech startups. Yet progress often felt incremental—punctuated by setbacks, safety concerns, and regulatory hesitation. Then, 2026 changed the tempo. This year marks a structural shift in how gene therapy is developed, delivered, and scaled.…
For centuries, medicine has fought disease at the macro level. We swallow pills. We undergo surgery. We inject therapies into the bloodstream and hope they reach the right target. Treatments circulate broadly, often affecting healthy tissue alongside diseased cells. Nanotechnology changes that paradigm entirely. Instead of treating illness with blunt instruments, nanotechnology operates at the…